Jacquelyn Robinson, MD
Obstetrics & Gynecology · Saginaw, MINPI 1144490590
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 32.9% of the total.
Across 67 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$416
- Hologic Sales And Service, LLC$148
- Astellas Pharma US Inc$131
- Aspira Women's Health Inc$90
- Biogen$72
- Sumitomo Pharma America, Inc.$63
- plus $342 from 12 others
Across 148 payments — averaging $3630.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$203K
- Exact Sciences$73K
- Ferring International Pharmascience Center US$61K
- Sumitomo Pharma America, Inc.$53K
- Myovant Sciences GmbH$38K
- Myovant Sciences Inc.$32K
- plus $77K from 5 others
What the payments were for
- Food & beverage$1,263100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $416 |
| Hologic Sales And Service, LLC | 7 | $148 |
| Astellas Pharma US Inc | 6 | $131 |
| Aspira Women's Health Inc | 2 | $90 |
| Biogen | 3 | $72 |
| Sumitomo Pharma America, Inc. | 3 | $63 |
| BD | 1 | $48 |
| Organon | 4 | $43 |
| Agile Therapeutics, Inc. | 3 | $43 |
| Boston Scientific | 2 | $40 |
| Coopersurgical, Inc. | 2 | $29 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Channel Medsystems, Inc. | 2 | $26 |
| Medtronic | 1 | $23 |
| Merck | 1 | $19 |
| Femselect Inc. | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $16 |
| Lupin Inc. | 1 | $13 |
How this compares
$1,263 in reported general payments places this provider in the 70th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 56 | $2,707 |
| Medroxyprogesterone Acetate | 13 | $389 |
| Clobetasol Propionate | 28 | $289 |
| Ibuprofen | 13 | $53 |
| Triamcinolone Acetonide | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Saginaw
- Tiffany KimSaginaw$16K
- Thomas MinnecSaginaw$9K
- David EisensteinDetroit$272K
- Peter TsengPort Huron$178K
- Robert ValiceChesterfield$175K
- Brent DavidsonDetroit$171K
- Michael EngelLake Orion$165K
- Ethan GoldsteinBloomfield Hills$140K
- Jay FisherWest Bloomfield$136K
- Barbara DepreeZeeland$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.